These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease. Stav AL, Aarsland D, Johansen KK, Hessen E, Auning E, Fladby T. Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633 [Abstract] [Full Text] [Related]
10. Reduced lateral occipital gray matter volume is associated with physical frailty and cognitive impairment in Parkinson's disease. Chen YS, Chen HL, Lu CH, Chen MH, Chou KH, Tsai NW, Yu CC, Chiang PL, Lin WC. Eur Radiol; 2019 May; 29(5):2659-2668. PubMed ID: 30523452 [Abstract] [Full Text] [Related]
11. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition. Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I. Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799 [Abstract] [Full Text] [Related]
12. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment. Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J. Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954 [Abstract] [Full Text] [Related]
17. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment. Pu W, Shen X, Huang M, Li Z, Zeng X, Wang R, Shen G, Yu H. Curr Neurovasc Res; 2020 Jul; 17(4):480-486. PubMed ID: 32875986 [Abstract] [Full Text] [Related]
18. Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease. Blommer J, Pitcher T, Mustapic M, Eren E, Yao PJ, Vreones MP, Pucha KA, Dalrymple-Alford J, Shoorangiz R, Meissner WG, Anderson T, Kapogiannis D. Brain; 2023 Jan 05; 146(1):195-208. PubMed ID: 35833836 [Abstract] [Full Text] [Related]